ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 253

$492K Total Retail Price of All Prescriptions

Rank: 5 out of 253

219 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 219 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

28% of this provider’s 219 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 2,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $70 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
HYDROCODONE-ACETAMINOPHEN 331 88 S3 1 3
LISINOPRIL 329 144 2 1
LEVOTHYROXINE SODIUM 304 145 3 2
AMLODIPINE BESYLATE 277 162 4 7
ATORVASTATIN CALCIUM 256 88 5 17
RANITIDINE HCL 222 91 6 18
SIMVASTATIN 208 66 7 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 54 8 22
METFORMIN HCL 197 93 9 6
ZOLPIDEM TARTRATE 194 68 10 19
TRILIPIX 193 71 11 76
OMEPRAZOLE 180 77 12 5
TRAMADOL HCL 171 32 13 12
PROAIR HFA 160 50 14 29
VENTOLIN HFA 133 50 15 73
CRESTOR 120 73 16 35
GABAPENTIN 109 39 17 8
ADVAIR DISKUS 100 67 18 44
CITALOPRAM HBR 96 24 19 36
CARISOPRODOL 94 25 R 20 66
SPIRIVA 92 34 21 52
SYMBICORT 88 32 22 113
PROMETHAZINE HCL 86 0 R 23 68
OXYCODONE HCL 85 19 S2 24 10
PRAVASTATIN SODIUM 84 33 25 51
CARVEDILOL 82 15 26 48
OXYCODONE-ACETAMINOPHEN 80 13 S2 27 14
LIPITOR 75 26 28 61
MORPHINE SULFATE ER 75 0 S2 28 20
ENDOCET 69 0 S2 30 101
PROPRANOLOL HCL 69 23 30 99
LOVAZA 69 0 30 95
GLIPIZIDE 68 12 33 50
LYRICA 68 11 33 43
FLUOXETINE HCL 67 12 35 82
POTASSIUM CHLORIDE 63 24 36 24
HYDROCHLOROTHIAZIDE 62 30 37 9
OXYCONTIN 61 0 S2 38 21
AMITRIPTYLINE HCL 60 28 R 39 55
AZITHROMYCIN 59 22 40 64
METOPROLOL TARTRATE 59 21 40 16
ROPINIROLE HCL 58 14 42 149
NIASPAN 57 12 43 154
TRAZODONE HCL 56 27 44 47
OXYCODONE HCL-ACETAMINOPHEN 54 11 S2 45 40
CLONIDINE HCL 51 34 46 103
CYCLOBENZAPRINE HCL 50 19 R 47 45
SINGULAIR 50 22 47 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.